Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies

Bayer

Market Cap: €19.8b

Operates as a life science company worldwide.

Merck KGaA

Market Cap: €50.1b

Operates as a science and technology company in Germany.

Viatris

Market Cap: €9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Regeneron Pharmaceuticals

Market Cap: €59.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Mettler-Toledo International

Market Cap: €21.7b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

IQVIA Holdings

Market Cap: €25.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Merck

Market Cap: €199.2b

Operates as a healthcare company worldwide.

Gerresheimer

Market Cap: €1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Almirall

Market Cap: €2.0b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Avantor

Market Cap: €10.4b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Teva Pharmaceutical Industries

Market Cap: €15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

H. Lundbeck

Market Cap: €27.0b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.5b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany.

Bristol-Myers Squibb

Market Cap: €103.2b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

H. Lundbeck

Market Cap: €27.0b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Ipsen

Market Cap: €7.8b

Operates as a biopharmaceutical company worldwide.

Danaher

Market Cap: €135.0b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Novavax

Market Cap: €942.5m

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Biogen

Market Cap: €16.9b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Gilead Sciences

Market Cap: €129.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: €124.3b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Tilray Brands

Market Cap: €485.9m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Evotec

Market Cap: €950.4m

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

UCB

Market Cap: €25.4b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Bavarian Nordic

Market Cap: €11.3b

Develops, manufactures, and supplies life-saving vaccines.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Eurofins Scientific

Market Cap: €8.9b

Provides various analytical testing and laboratory services worldwide.

CureVac

Market Cap: €715.6m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Valneva

Market Cap: €450.5m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Thermo Fisher Scientific

Market Cap: €165.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Takeda Pharmaceutical

Market Cap: €6.0t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

argenx

Market Cap: €31.1b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €9.6b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Sanofi

Market Cap: €109.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Novo Nordisk

Market Cap: €1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.